Home › Abbvie 'Enhanzes' Halozyme Therapeutics coffers in potential $1.193B collaboration
 

Keywords :   


Abbvie 'Enhanzes' Halozyme Therapeutics coffers in potential $1.193B collaboration

2015-06-04 06:37:32| Logistics - Topix.net

Fresh off reporting good news at the American Society of Clinical Oncology annual meeting in Chicago, Halozyme Therapeutics Inc. segued into yet another global collaboration and license agreement - this time with Abbvie Inc. - that could add $1.193 billion to its coffers. The deal allows Abbvie, of North Chicago, to apply Halozyme's Enhanze delivery platform to up to nine of its compounds in return for $23 million up front to Halozyme and milestone payments totaling approximately $130 million for each collaboration target.

Tags: potential collaboration therapeutics coffers

Category:Transportation and Logistics

Latest from this category

All news
03.07Hurricane Beryl Graphics
03.07Hurricane Beryl Forecast Discussion Number 20
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Public Advisory Number 20
03.07Hurricane Beryl Forecast Advisory Number 20
03.07Hurricane Beryl Graphics
03.07Summary for Hurricane Beryl (AT2/AL022024)
03.07Hurricane Beryl Public Advisory Number 19A
Transportation and Logistics »
03.07Genesus to restructure with Canada ZF Investments
03.07Global trade, domestic policy: What's at stake for pork industry
03.07Over 20,000 Tesco staff to split 30m from share schemes
03.07Ex-Post Office chair denies hiding key Horizon report
03.07Print Quest invests in two more Miraclon Shine LED lamp kits
03.07ETI celebrates grand opening of new headquarters in Spain
03.07Mondi unveils FlexiBag Reinforced
03.07Nilpeter announces new partnership in the Philippines
More »